178 related articles for article (PubMed ID: 36229145)
1. Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.
Manyara AM; Davies P; Stewart D; Wells V; Weir C; Young A; Taylor R; Ciani O
BMJ Open; 2022 Oct; 12(10):e062798. PubMed ID: 36229145
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.
Manyara AM; Davies P; Stewart D; Weir CJ; Young A; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
BMJ Open; 2022 Oct; 12(10):e064304. PubMed ID: 36220321
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
4. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
7. Surrogate endpoints in trials: a call for better reporting.
Ciani O; Manyara AM; Chan AW; Taylor RS;
Trials; 2022 Dec; 23(1):991. PubMed ID: 36503559
[TBL] [Abstract][Full Text] [Related]
8. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
[TBL] [Abstract][Full Text] [Related]
9. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
Trials; 2015 Sep; 16():417. PubMed ID: 26385379
[TBL] [Abstract][Full Text] [Related]
10. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
13. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
[TBL] [Abstract][Full Text] [Related]
14. Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data.
Kwakkenbos L; Imran M; McCord KA; Sampson M; Fröbert O; Gale C; Hemkens LG; Langan SM; Moher D; Relton C; Zwarenstein M; Benchimol EI; Boutron I; Campbell MK; Erlinge D; Jawad S; Ravaud P; Rice DB; Sauve M; van Staa TP; Thabane L; Uher R; Verkooijen HM; Juszczak E; Thombs BD
BMJ Open; 2018 Aug; 8(8):e025266. PubMed ID: 30082372
[TBL] [Abstract][Full Text] [Related]
15. Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
Manyara AM; Davies P; Stewart D; Weir CJ; Young AE; Wells V; Blazeby J; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
J Clin Epidemiol; 2023 Aug; 160():83-99. PubMed ID: 37380118
[TBL] [Abstract][Full Text] [Related]
16. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.
Speich B; Mann E; Schönenberger CM; Mellor K; Griessbach AN; Dhiman P; Gandhi P; Lohner S; Agarwal A; Odutayo A; Puebla I; Clark A; Chan AW; Schlussel MM; Ravaud P; Moher D; Briel M; Boutron I; Schroter S; Hopewell S
JAMA Netw Open; 2023 Jun; 6(6):e2317651. PubMed ID: 37294569
[TBL] [Abstract][Full Text] [Related]
17. Protocol for a meta-research study of protocols for diet or nutrition-related trials published in indexed journals: general aspects of study design, rationale and reporting limitations.
Silva FM; Adegboye ARA; Curioni C; Gomes FS; Collins GS; Kac G; A De Beyer J; Cook JA; Cheikh Ismail L; Page MJ; Khandpur N; Lamb S; Hopewell S; Kirtley S; Durão S; Vorland CJ; M Schlussel M
BMJ Open; 2022 Dec; 12(12):e064744. PubMed ID: 36572499
[TBL] [Abstract][Full Text] [Related]
18. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
[TBL] [Abstract][Full Text] [Related]
19. Guidance for reporting outcomes in clinical trials: scoping review protocol.
Butcher NJ; Mew EJ; Saeed L; Monsour A; Chee-A-Tow A; Chan AW; Moher D; Offringa M
BMJ Open; 2019 Feb; 9(2):e023001. PubMed ID: 30782872
[TBL] [Abstract][Full Text] [Related]
20. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.
Ciani O; Manyara AM; Davies P; Stewart D; Weir CJ; Young AE; Blazeby J; Butcher NJ; Bujkiewicz S; Chan AW; Dawoud D; Offringa M; Ouwens M; Hróbjartssson A; Amstutz A; Bertolaccini L; Bruno VD; Devane D; Faria CDCM; Gilbert PB; Harris R; Lassere M; Marinelli L; Markham S; Powers JH; Rezaei Y; Richert L; Schwendicke F; Tereshchenko LG; Thoma A; Turan A; Worrall A; Christensen R; Collins GS; Ross JS; Taylor RS
EClinicalMedicine; 2023 Nov; 65():102283. PubMed ID: 37877001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
